The VEGF pathway inhibitors include sorafenib, sunitinib, bevacizumab, pazopanib, and axitinib, which mainly prevent tumor growth and invasion by inhibiting tumor angiogenesis. The gene discussed is VEGFA; the disease is neoplasm.